PLAVIX - 16590-288-60 - (CLOPIDOGREL BISULFATE)

Alphabetical Index


Drug Information of PLAVIX

Product NDC: 16590-288
Proprietary Name: PLAVIX
Non Proprietary Name: CLOPIDOGREL BISULFATE
Active Ingredient(s): 75    mg/1 & nbsp;   CLOPIDOGREL BISULFATE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of PLAVIX

Product NDC: 16590-288
Labeler Name: STAT RX USA LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020839
Marketing Category: NDA
Start Marketing Date: 19000101

Package Information of PLAVIX

Package NDC: 16590-288-60
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16590-288-60)

NDC Information of PLAVIX

NDC Code 16590-288-60
Proprietary Name PLAVIX
Package Description 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16590-288-60)
Product NDC 16590-288
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CLOPIDOGREL BISULFATE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19000101
Marketing Category Name NDA
Labeler Name STAT RX USA LLC
Substance Name CLOPIDOGREL BISULFATE
Strength Number 75
Strength Unit mg/1
Pharmaceutical Classes Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]

Complete Information of PLAVIX


General Information